Correlation Between Acumen Pharmaceuticals and Immunoprecise Antibodies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Immunoprecise Antibodies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Immunoprecise Antibodies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Immunoprecise Antibodies, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Immunoprecise Antibodies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Immunoprecise Antibodies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Immunoprecise Antibodies.

Diversification Opportunities for Acumen Pharmaceuticals and Immunoprecise Antibodies

  Correlation Coefficient

Good diversification

The 3 months correlation between Acumen and Immunoprecise is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Immunoprecise Antibodies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunoprecise Antibodies and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Immunoprecise Antibodies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunoprecise Antibodies has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Immunoprecise Antibodies go up and down completely randomly.

Pair Corralation between Acumen Pharmaceuticals and Immunoprecise Antibodies

Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to generate 0.91 times more return on investment than Immunoprecise Antibodies. However, Acumen Pharmaceuticals is 1.1 times less risky than Immunoprecise Antibodies. It trades about 0.11 of its potential returns per unit of risk. Immunoprecise Antibodies is currently generating about -0.16 per unit of risk. If you would invest  345.00  in Acumen Pharmaceuticals on March 26, 2022 and sell it today you would earn a total of  30.00  from holding Acumen Pharmaceuticals or generate 8.7% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
ValuesDaily Returns

Acumen Pharmaceuticals  vs.  Immunoprecise Antibodies

 Performance (%) 
Acumen Pharmaceuticals 
Acumen Performance
0 of 100
Over the last 90 days Acumen Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in July 2022. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Acumen Price Channel

Immunoprecise Antibodies 
Immunoprecise Performance
1 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Immunoprecise Antibodies are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Immunoprecise Antibodies may actually be approaching a critical reversion point that can send shares even higher in July 2022.

Structure and Payout Changes

Last Split Factor
Dividend Date
Last Split Date

Immunoprecise Price Channel

Acumen Pharmaceuticals and Immunoprecise Antibodies Volatility Contrast

 Predicted Return Density 

Pair Trading with Acumen Pharmaceuticals and Immunoprecise Antibodies

The main advantage of trading using opposite Acumen Pharmaceuticals and Immunoprecise Antibodies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Immunoprecise Antibodies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunoprecise Antibodies will offset losses from the drop in Immunoprecise Antibodies' long position.
The idea behind Acumen Pharmaceuticals and Immunoprecise Antibodies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Screener module to find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Global Correlations
Find global opportunities by holding instruments from different markets
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas